Clinical Trials Sponsored by Strategic Biosciences

Total 1963 results

Strategic Biosciences

Unknown

Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis (SMAN)

Allergic Rhinitis

United States
Daré Bioscience, Inc.
Strategic Science & Technologies, LLC

Recruiting

Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%

Sexual Arousal Disorder

Canada
Strategic Science & Technologies, LLC
Daré Bioscience, Inc.

Recruiting

Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder (RESPOND)

Female Sexual Arousal Disorder

United States
Quadram Institute Bioscience
The Danish Council for Strategic Research

Completed

Effects of Brassica on Human Gut Lactobacilli (EBL)

Human Gut Microbiota

United Kingdom
Anwita Biosciences
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Phase 1 First-in-human Study of JS014

Lymphoma | Solid Tumor, Adult | Neoplasm Malignant | Neoplasm, Experimental

Taiwan
Strategic Science & Technologies, LLC

Completed

Efficacy and Safety of SST 0225, a Topical Ibuprofen Cream, in the Treatment of Pain Associated With Acute Ankle Sprain

Acute Ankle Sprain

United States
Strategic Science & Technologies, LLC

Completed

Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder

Sexual Arousal Disorder

United States
Strategic Science & Technologies, LLC

Completed

Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS) (DOMS)

Delayed Onset Muscle Soreness, DOMS

United States
Strategic Science & Technologies, LLC

Completed

Dosing Interval Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DIS DOMS)

Delayed Onset Muscle Soreness

United States
Strategic Science & Technologies, LLC

Completed

Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults

Healthy

United States
Strategic Science & Technologies, LLC

Completed

Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED

Erectile Dysfunction

United States
Strategic Science & Technologies, LLC

Completed

A Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Safety and Pharmacokinetic Profile of a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women

Female Sexual Health

United States
Strategic Science & Technologies, LLC

Completed

Single-Dose Relative Bioavailability Study of SST-6006, a Topical Sildenafil Cream Versus Oral Sildenafil in Healthy Male Adults

Healthy

United States
Quadram Institute Bioscience
Biotechnology and Biological Sciences Research Council; The Danish Council...

Completed

The Conversion of ENcapsulated GlucorAphanin, Gut Microbiota Phylogeny and gEnotype Study (ENGAGE) (ENGAGE)

Healthy

United Kingdom
Coherus Biosciences, Inc.
Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.

Active, not recruiting

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Hepatocellular Carcinoma | Non-Small Cell Lung Cancer | Advanced Solid Tumor

United States
Prevention Strategies, LLC

Completed

Implementation of a Web-based Alcohol and Other Drug Prevention Intervention for Collegiate Student-athletes

Alcohol Drinking | Harm Reduction | Social Norms | Expectations
YM BioSciences
CIMYM BioSciences

Terminated

A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases

Metastatic Non-Small Cell Lung Cancer

United States, Korea, Republic of, Canada, Cuba, Pakistan
YM BioSciences
CIMYM BioSciences

Terminated

A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

Non-small-cell Lung Cancer

Canada, United States, Singapore
YM BioSciences
CIMYM BioSciences

Completed

Phase I Study of Nimotuzumab in Solid Tumours

Advanced and/or Metastatic Solid Tumours

Canada
Shanghai Junshi Bioscience Co., Ltd.
Iqvia Pty Ltd; TopAlliance Biosciences, Inc.

Active, not recruiting

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Advanced Malignancies

United States
M.D. Anderson Cancer Center
STRATEGIC ALLIANCE: Merck

Recruiting

A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma

Adenocarcinoma | Tumor

United States
Lund University
Swedish Foundation for Strategic Research

Completed

Health Effects of Oats and Oat Bioactive in Human

Postprandial Glucose Regulation

Sweden
Lund University
Swedish Foundation for Strategic Research

Completed

Health Effects of Oat Bioactives (Betaglucan) in Human

Healthy

Sweden
Lund University
Swedish Foundation for Strategic Research

Completed

Health Effects of Oat and Oat Polar Lipids in Human

Postprandial Glucose Regulation

Sweden
Janssen Research & Development, LLC
Cegedim Strategic Data

Completed

PRILIGY Usage Patterns in Selected Populations

Sexual Dysfunction, Physiological
LegoChem Biosciences, Inc
AntibodyChem Biosciences, Inc.

Recruiting

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Advanced Solid Tumors

United States, Canada
Lund University
Swedish Foundation for Strategic Research

Completed

Health Effects of Oat and Oat Bioactive in Human

Postprandial Glucose Regulation

Sweden
VA Pharmacy Benefits Management Strategic Healthcare...

Completed

Tolerance to Target Doses of Thiazides in Actual Practice: A Feasibility Study

Hypertension

United States
Senti Biosciences

Not yet recruiting

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

AML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological Malignancies
Euromi Biosciences

Recruiting

Prospective Observational Clinical Follow-up of Euromi Biosciences Pre-filled Silicone Gel Breast Implants (ELEGANT)

Breast Implant Rupture | Breast Implant; Complications

France
IDEAYA Biosciences

Recruiting

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Metastatic Uveal Melanoma

United States, Canada, Israel, Spain, Australia, Germany, France, Italy, United Kingdom, Netherlands, Belgium, Poland, Switzerland
Sanguine Biosciences

Recruiting

Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

Chronic Granulomatous Disease

United States
Sanguine Biosciences

Recruiting

Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b)

Glycogen Storage Disease Type IB

United States
Sanguine Biosciences

Recruiting

Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia

Fanconi Anemia

United States
IDEAYA Biosciences

Recruiting

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Uveal Melanoma

United States, Netherlands, Australia, Canada, Italy, France, Germany, United Kingdom
Neurocrine Biosciences

Recruiting

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Tardive Dyskinesia | Major Depressive Disorder

United States
Sanguine Biosciences

Recruiting

Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research

Non Small Cell Lung Cancer

United States
Neurocrine Biosciences

Recruiting

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia

Schizophrenia

United States
Antiva Biosciences

Recruiting

A Study of ABI-2280 Vaginal Tablet in Participants With Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia

Australia, South Africa
Aura Biosciences

Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Muscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder Cancer

United States
Neurocrine Biosciences

Recruiting

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

Cerebral Palsy | Dyskinesia

United States, Argentina, Poland, Spain
Neurocrine Biosciences

Recruiting

Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

Schizophrenia

United States, Bulgaria, Serbia
RaND Biosciences

Not yet recruiting

A Phase 1/2 Study of SC-43 in Combination With Cisplatin

Advanced Biliary Tract Cancer | Advanced Non-small-cell Lung Cancer
IDEAYA Biosciences

Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Colorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid Tumors

United States, Australia, Canada
Aura Biosciences

Recruiting

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Choroidal Melanoma | Indeterminate Lesions of Eye

United States
Neurocrine Biosciences

Terminated

Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

Focal Onset Seizure | Focal Onset Epilepsy

Spain, Australia, Belgium, Czechia, France, Hungary, Italy
Novadip Biosciences

Active, not recruiting

Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion

Recalcitrant Lower Limb Nonunion

Luxembourg, Belgium, Switzerland
KBP Biosciences

Completed

Safety, Tolerability and Pharmacokinetics of KBP-7072

Healthy

United States
Aura Biosciences

Completed

Study in Subjects With Small Primary Choroidal Melanoma

Ocular Melanoma | Uveal Melanoma | Choroidal Melanoma

United States
Neurocrine Biosciences

Terminated

Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia

Schizophrenia

United States

Clinical Trials Sponsored by Strategic Biosciences

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations